Lopinavir and Ritonavir Tablet — FDA Drug Shortage

To Be Discontinued — AbbVie Inc.

The FDA lists a drug shortage record for Lopinavir and Ritonavir Tablet (tablet) from AbbVie Inc. with status To Be Discontinued. The shortage was first posted on 07/24/2026.

Shortage Details

Status
To Be Discontinued
Company
AbbVie Inc.
Package NDC
0074-6799-22
Dosage Form
Tablet
Presentation
Kaletra, Tablet, 200 mg; 50 mg (NDC 0074-6799-22)
Initial Posting
07/24/2026
Revised Date